The 4th Tumor Myeloid Targeting Therapies Summit 2024, scheduled from June 11th to 13th, 2024, highlights the burgeoning landscape of innate immune cells in clinical applications. Recent studies emphasize the efficacy of targeting myeloid cells to shrink tumors, enhancing confidence in their therapeutic potential. This annual summit convenes innate immunity experts from biopharma and academia to showcase novel clinical practices across multiple myeloid subsets, including macrophages, MDSCs, neutrophils, and dendritic cells. Attendees will learn about translational lessons, novel targets, and the complexities of the tumor microenvironment from leading institutions and companies such as MD Anderson, Gilead Sciences, Onchilles Pharma, DEM Biopharma, and NGM Biopharma.

 [Read on tumor-myeloid-therapeutics.com/](https://tumor-myeloid-therapeutics.com/)

The 40th Annual Geriatric Care 2024 CNE Nursing Conference is scheduled for Tuesday, June 11, 2024, from 07:00 to 17:00. Designed for healthcare professionals in acute, long-term, and home care settings, including registered nurses, licensed practical nurses, social workers, nursing home administrators, and nurse practitioners, the conference offers insights into advancements in geriatric patient care. Topics include behavioral health, ethics, cultural care, medications, transitions, wound care, and more. Expert panels and case scenarios facilitate discussions and Q&A sessions. Participants will gain strategies for managing behavioral health issues, medication considerations, and insights into cultural and ethical principles in elderly patient care.

 [Read on ce.mayo.edu](https://ce.mayo.edu/nursing/content/40th-annual-geriatric-care-2024-cne-nursing-conference#group-tabs-node-course-default1)

SAE Media Group announces the return of the 8th Annual Pre-Filled Syringes West Coast Conference in 2024, convening device developers, biotech, and big pharma in the West Coast. Scheduled for June 10th to 11th, 2024, the conference will delve into advances in combination product drug delivery and explore collaborative strategies among pharma, device developers, and regulators to foster innovation. Positioned as a leading event in injectable drug delivery, attendees can expect valuable insights to enrich their drug device portfolios and networking opportunities with industry leaders. SAE looks forward to welcoming participants to this essential gathering in June 2024.

 [Read on www.smgconferences.com](https://www.smgconferences.com/pharmaceuticals/northamerica/conference/Pre-Filled-Syringes-West-Coast/booknow)

With 2024 marked as a critical juncture for Talent Acquisition (TA) teams in the European Life Science sector, anticipation brews for the debut of LEAP TA: Life Sciences Europe. Scheduled for June in London, this exclusive summit aims to illuminate the advancements propelling biopharma talent acquisition strategies forward in 2024 and beyond. The industry grapples with transformative shifts, from digitization to impending patent expirations, reshaping talent requirements. Addressing skill mismatches and recruiting seasoned professionals emerge as pressing concerns. Consequently, strategic recalibration is imperative for Life Science enterprises to navigate these challenges effectively. Particularly in Europe, intricate country-specific regulations amplify recruitment complexities, necessitating a nuanced approach. 

[Read on leap-ta-lifesciences-europe.com](https://leap-ta-lifesciences-europe.com/take-part/register/)

The 2024 International Conference on Medical, Medicine, and Health Sciences (ICMMH-2024) is scheduled for June 8th to 9th, 2024, in Boston, United States of America. This conference will delve into crucial issues within medical, medicine, and health sciences, covering various sub-themes. Its primary objective is to facilitate networking, knowledge sharing, publication opportunities, and the professional development of scholars worldwide. ICMMH-2024 aims to assemble leading academic scientists, professors, researchers, students, and scholars to exchange experiences and research findings. It serves as a premier interdisciplinary forum for discussing recent innovations, trends, challenges, and solutions in the field of Medical and Health Sciences.

Read on iierd.com

The Eurasia International Conference on Bioinformatics, Biomedicine, Biotechnology, and Computational Biology (EUIC3BCB - 2024) will be hosted in Detroit, USA, on 8th-9th June 2024. This conference serves as a recurring interactive platform for global professionals to discuss advancements in these fields. Participants exploring career opportunities or professional ties are welcome. It acts as an ideal forum for networking and relationship building. The event facilitates knowledge exchange among professionals involved in Bioinformatics, Biomedicine, Biotechnology, and Computational Biology, showcasing technological advancements and solutions used worldwide. Stakeholders from research, academia, industry, and government sectors convene, fostering collaboration and sharing insights into current practices and advancements in Biotechnology.

Read on eurasiaweb.com

The 2nd Annual Advancing Life Science Construction conference is set to reconvene in June 2024, emphasizing the urgency of aligning project delivery with rapid scientific and technological advancements. Aimed at the Architecture, Engineering, and Construction (AEC) community, this event aims to address critical challenges spanning the life science facility lifecycle. Attendees will explore emerging market trends, owner preferences, and strategies for expediting project timelines while prioritizing adaptability, sustainability, and resilience. By delving into best practices, participants can equip their project teams to excel in meeting client expectations for quality, profitability, and speed-to-market, positioning their firms as leaders in delivering excellence both now and in the future.

 [Read on advancing-life-science](https://advancing-life-science-construction.com/get-involved/register/)

The 62nd Annual PTCOG Conference invites you to join the foremost innovators and thought leaders in the field of particle therapy. This premier event offers a gateway to the latest advancements, networking, and professional growth in cancer treatment. PTCOG boasts 16 active Sub-Committees, fostering collaboration and reporting on their activities. This year, the Scholar-in-Training (SIT) Sub-Committee contributes to educational and scientific program planning, engaging younger generations in leadership. Discussions include funding for research projects and the future of the International Journal of Particle Therapy. Join us from June 10 to June 15, 2024, to be part of the PTCOG community dedicated to advancing particle therapy.

Read on ptcog62.org

The International Conference on Artificial Intelligence for Healthcare, to be held on June 07-08, 2025, in San Francisco, United States, adopts a hybrid format to accommodate diverse scholarly events, facilitated by the International Research Conference. Throughout the conference, a variety of presentations will unfold, their duration contingent upon the volume and length of discussions. Esteemed academic scientists, researchers, and scholars will convene to exchange insights and share research outcomes encompassing all facets of Artificial Intelligence for Healthcare. This interdisciplinary platform serves as a conduit for exploring recent innovations, trends, and challenges, fostering discussions among practitioners, educators, and industry researchers to address practical issues and exchange adopted solutions.

Read on waset.org

The Mayo Clinic's Transforming Women's Health course, scheduled for June 6-8, 2024, aims to enhance the care of women by incorporating emerging scientific and clinical evidence. Tailored for healthcare practitioners, it covers unique medical conditions in women, those more prevalent in women, or exhibiting gender-specific differences. Specialties include obstetrics, gynecology, reproductive and sexual health, menopausal medicine, cardiology, endocrinology, internal medicine, and preventive medicine. The learning objectives encompass updated recommendations for non-hormone treatments for vasomotor symptoms, principles of hormone therapy in transgender individuals, and addressing menopause symptoms' impact in the workplace. The diverse audience includes physicians, nurse practitioners, physician assistants, nurses, and other healthcare professionals interested in women's health.

 [Read on ce.mayo.edu](https://ce.mayo.edu/internal-medicine/content/transforming-womens-health-2024)